Our team has unique experience in providing diverse specialised services for innovative commercial enterprises in the biomedicine and biotechnology sector.

What sets BMC apart is our strong focus on one specialised industry. This enables us to guarantee a complete synergy of services in the field. We offer comprehensive services for innovation and innovation process management:

• valuation of intangible assets;
• detailed market and competitor analysis;
• transaction advisory services for in-/out-licensing;
• obtaining seed capital/venture and private equity capital funding
• interim management – an overall temporary provision of management resources and skills.

We prepare our analyses using the highest quality data sources and tools, including databases of renowned companies, and professional interviews with primary sources (e.g. industry experts), as well as through the use of advanced analytical tools. We take particular pride in our methodologies for biopharmacy and medical device valuation, which are unique on a national scale. Drawing on the world’s best models we have developed these tools in-house.

BMC’s full integration into a dynamic environment of experienced investors, consultants and independent experts, often with international experience and success, is an additional quality assurance of our services.
Our partners include venture capital and private equity funds as well as technology transfer units.

BMC’s close cooperation with competent partners is carried out in a manner that assures our complete independence – a unique feature in the industry. We are not affiliated with any research institute or investment fund.